Voyager Therapeutics (VYGR) EBT (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.85% |
| Dec 31, 2025 | 1.41% |
| Sep 30, 2025 | 16.66% |
| Jun 30, 2025 | -7.69% |
| Mar 31, 2025 | 8.61% |
| Dec 31, 2024 | -276.66% |
| Sep 30, 2024 | 11.03% |
| Jun 30, 2024 | 10.60% |
| Mar 31, 2024 | -119.78% |
| Dec 31, 2023 | 319.41% |
| Sep 30, 2023 | -17.74% |
| Jun 30, 2023 | -117.75% |
| Mar 31, 2023 | 628.37% |
| Dec 31, 2022 | -233.97% |
| Sep 30, 2022 | 192.34% |
| Jun 30, 2022 | 10.47% |
| Mar 31, 2022 | -521.41% |
| Dec 31, 2021 | 120.22% |
| Sep 30, 2021 | 12.31% |
| Jun 30, 2021 | -11.60% |
| Mar 31, 2021 | -8.13% |
| Dec 31, 2020 | -127.89% |
| Sep 30, 2020 | 1,081.83% |
| Jun 30, 2020 | 63.18% |
| Mar 31, 2020 | -86.54% |
| Dec 31, 2019 | 16.21% |
| Sep 30, 2019 | -234.55% |
| Jun 30, 2019 | 141.05% |
| Mar 31, 2019 | -20.59% |
| Dec 31, 2018 | -11.05% |
| Sep 30, 2018 | 20.56% |
| Jun 30, 2018 | -27.03% |
| Mar 31, 2018 | -70.42% |
| Dec 31, 2017 | 49.46% |
| Sep 30, 2017 | -24.97% |
| Jun 30, 2017 | -10.71% |
| Mar 31, 2017 | -17.85% |
| Dec 31, 2016 | -53.97% |
| Sep 30, 2016 | 0.39% |
| Jun 30, 2016 | -29.87% |
| Mar 31, 2016 | 1.30% |
| Dec 31, 2015 | -85.93% |
| Sep 30, 2015 | -2.49% |
| Jun 30, 2015 | 73.78% |
| Mar 31, 2015 | -210.81% |
| Dec 31, 2014 | -17.10% |